Healthcare provider profile · identity verified

Ebony N Pratt, M.D.

Family Practice · JACKSONVILLE, FL · NPI 1740243377

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	477	149
Atorvastatin Calcium	Atorvastatin Calcium	455	139
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	410	65
Gabapentin	Gabapentin	365	92
Metformin Hcl	Metformin Hcl	314	89
Losartan Potassium	Losartan Potassium	260	81
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	215	31
Omeprazole	Omeprazole	202	66
Lisinopril	Lisinopril	191	64
Albuterol Sulfate Hfa	Albuterol Sulfate	185	51
Hydrochlorothiazide	Hydrochlorothiazide	178	60
Tizanidine Hcl	Tizanidine Hcl	178	47
Metoprolol Succinate	Metoprolol Succinate	148	44
Pregabalin	Pregabalin	147	27
Fluticasone Propionate	Fluticasone Propionate	146	46
Pantoprazole Sodium	Pantoprazole Sodium	138	40
Levothyroxine Sodium	Levothyroxine Sodium	134	38
Trazodone Hcl	Trazodone Hcl	124	31
Furosemide	Furosemide	122	45
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	121	28
Ibuprofen	Ibuprofen	119	45
Carvedilol	Carvedilol	116	42
Ozempic	Semaglutide	113	21
Ventolin Hfa	Albuterol Sulfate	102	34
Famotidine	Famotidine	99	24
Pravastatin Sodium	Pravastatin Sodium	93	30
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	90	21
Hydroxyzine Hcl	Hydroxyzine Hcl	81	24
Trulicity	Dulaglutide	78	12
Oxycodone Hcl	Oxycodone Hcl	76	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	73	31
Doxepin Hcl	Doxepin Hcl	68	14
Zolpidem Tartrate	Zolpidem Tartrate	60	suppressed
Montelukast Sodium	Montelukast Sodium	59	18
Spironolactone	Spironolactone	58	23
Potassium Chloride	Potassium Chloride	57	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	15
Allopurinol	Allopurinol	51	14
Hydralazine Hcl	Hydralazine Hcl	50	17
Clopidogrel	Clopidogrel Bisulfate	49	13
Meclizine Hcl	Meclizine Hcl	49	19
Meloxicam	Meloxicam	49	17
Mounjaro	Tirzepatide	49	suppressed
Tramadol Hcl	Tramadol Hcl	49	14
Triamcinolone Acetonide	Triamcinolone Acetonide	48	15
Jardiance	Empagliflozin	46	15
Rosuvastatin Calcium	Rosuvastatin Calcium	44	19
Symbicort	Budesonide/Formoterol Fumarate	44	14
Valsartan	Valsartan	44	15
Buspirone Hcl	Buspirone Hcl	41	suppressed
Alendronate Sodium	Alendronate Sodium	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	39	suppressed
Lidocaine	Lidocaine	39	11
Mirtazapine	Mirtazapine	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Eliquis	Apixaban	36	16
Tamsulosin Hcl	Tamsulosin Hcl	35	16
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Celecoxib	Celecoxib	34	13
Diclofenac Sodium	Diclofenac Sodium	34	15
Terazosin Hcl	Terazosin Hcl	34	11
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Bumetanide	Bumetanide	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Nifedipine Er	Nifedipine	31	11
Novolog	Insulin Aspart	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Methocarbamol	Methocarbamol	30	14
Simvastatin	Simvastatin	30	11
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Ondansetron Odt	Ondansetron	28	13
Amoxicillin	Amoxicillin	27	21
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	12
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	11
Farxiga	Dapagliflozin Propanediol	25	suppressed
Fluconazole	Fluconazole	25	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Nystatin	Nystatin	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Baclofen	Baclofen	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Prednisone	Prednisone	23	17
Trueplus Pen Needle	Pen Needle, Diabetic	23	suppressed
Colchicine	Colchicine	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Levemir Flexpen	Insulin Detemir	22	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Levemir	Insulin Detemir	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	20	suppressed
Atenolol	Atenolol	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Estradiol (Once Weekly)	Estradiol	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Glipizide	Glipizide	19	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	19	suppressed
Restasis	Cyclosporine	19	suppressed
Torsemide	Torsemide	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Humalog	Insulin Lispro	18	suppressed
Lactulose	Lactulose	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Linzess	Linaclotide	17	suppressed
Naproxen	Naproxen	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Risperidone	Risperidone	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Letrozole	Letrozole	15	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	15	suppressed
Aimovig Autoinjector	Erenumab-Aooe	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Enulose	Lactulose	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Indapamide	Indapamide	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error